Records containing: Type 2 Diabetes

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2012-03-20
  Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
• CLINICAL_TRIALS study record update · 2012-03-08
  Lantus for Diabetic Patients Treated in Clalit Outpatient Clinics
• CLINICAL_TRIALS study record update · 2012-03-08
  A 24-Week International, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Therapy
• CLINICAL_TRIALS study record update · 2012-03-02
  ClinicalTrials.gov study NCT01542775
• CLINICAL_TRIALS study record update · 2012-03-01
  A 24-week National Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase III Trial in India to Evaluate the Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone.
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-02-27
  An Evaluation and Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References
• CLINICAL_TRIALS study record update · 2012-02-23
  Association of HBA1C and Hip Fractures in Elderly Type 2 Diabetic Patients
• CLINICAL_TRIALS study record update · 2012-02-17
  ClinicalTrials.gov study NCT01415726
• CLINICAL_TRIALS study record update · 2012-02-13
  A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD7687 After Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects
• CLINICAL_TRIALS study record update · 2012-02-09
  Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing Whose Maturation Depends on the Protein HuR, Including Gene Encoding Insulin Receptor
• CLINICAL_TRIALS study record update · 2012-02-07
  A Prospective Randomised Study Comparing Billroth II With Roux-en-Y Reconstruction After Radical Distal Subtotal Gastrectomy for Gastric Cancer Comorbid With Type 2 Diabetes
• CLINICAL_TRIALS study record update · 2012-02-02
  A Randomized, Single-Blind, Placebo-Controlled, Single-Center, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Fasting After Single Ascending Oral Doses of AZD5658 in Type 2 Diabetes Mellitus Patients
• CLINICAL_TRIALS study record update · 2012-02-02
  Evaluation of the Tantalus System in Type 2 Diabetic Subjects
• CLINICAL_TRIALS study record update · 2012-01-30
  A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sitagliptin in Adolescents
• CLINICAL_TRIALS study record update · 2012-01-24
  Evaluation of the BALANCE System in Type 2 Diabetic Patients
• CLINICAL_TRIALS study record update · 2012-01-18
  A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Monotherapy or Metformin Therapy in Combination With Other Oral Anti-Diabetic Agents
• CLINICAL_TRIALS study record update · 2012-01-18
  A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetes With Inadequate Glycemic Control on Insulin Therapy Alone or Insulin Therapy Combination With Other Oral Anti-diabetic Agents
• CLINICAL_TRIALS study record update · 2012-01-18
  A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetics With Inadequate Glycemic Control on Sulfonylurea Monotherapy or Sulfonylurea Therapy in Combination With Other Oral Anti-Diabetic Agents
• CLINICAL_TRIALS study record update · 2012-01-16
  Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes
• CLINICAL_TRIALS study record update · 2012-01-16
  Comparison of Efficacy of Vitamin D and Vitamin D-calcium Fortified Yogurt Drink on Glycemic, Metabolic, Inflammatory, Immunity and Oxidative Stress Markers in Type 2 Diabetes
• CLINICAL_TRIALS study record update · 2012-01-11
  Comparative Investigation of Efficacy and Safety of Insulin Glargine Versus Metformin as First Line Drug in Treatment of Early Type 2 Diabetes
• CLINICAL_TRIALS study record update · 2012-01-11
  A Dose-Ranging Study to Evaluate Fasting and Postprandial P-Glucose, Safety and Tolerability After Oral Single, B.I.D and Q.I.D Dosing of AZD6370 in Patients With Diabetes Mellitus: a Randomized, Single-Blind, Placebo-Controlled, Phase I Study
• CLINICAL_TRIALS study record update · 2012-01-04
  A Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SLV337 in Patients With Type 2 Diabetes on Metformin Monotherapy
• CLINICAL_TRIALS study record update · 2011-12-14
  Impacts of Vitamin D Inadequacy on Postprandial Glucose Excursion in Patients With Type 2 Diabetes
• CLINICAL_TRIALS study record update · 2011-12-13
  A Multicenter, Randomized, Double-Blind, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Insulin Alone or on Insulin in Combination With Metformin